ReviewFrontiers in immunology2024

Current status and breakthroughs in treating advanced non-small cell lung cancer with EGFR exon 20 insertion mutations.

Meng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.